Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,663 across all filing types
Latest filing 2025-10-27 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Suspension from Quotation 2 pages 291.9KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the suspension of Anteris Technologies Global Corp.'s securities from quotation. It references ASX Listing Rule 17.2 and details the company's request for voluntary suspension pending a capital raising announcement. The document is short (2796 characters) and primarily serves as an official notice about the trading suspension, not a financial report or detailed disclosure. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-10-27 English
Capital Raise to Advance PARADIGM Trial & Commercialisation 42 pages 5.6MB
Regulatory Filings
2025-10-27 English
Proposed issue of securities - AVR 9 pages 30.7KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3B form, which is a standard ASX announcement format used for the proposed issue of securities, including placements and other types of capital raising. It details the number and types of securities to be issued, issue prices, attaching securities, and related conditions. The document is focused on the announcement of a capital raising event and the issuance of new securities, including warrants and common stock. It does not contain financial statements, earnings data, or management discussion of results. It is not a full financial report but rather a regulatory announcement about capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is not a brief report publication announcement or a simple regulatory filing. Confidence is high due to the clear presence of Appendix 3B and detailed issuance terms.
2025-10-27 English
Reinstatement to Quotation 1 page 113.8KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX Compliance regarding the reinstatement to quotation of Anteris Technologies Global Corp. It mentions the lifting of suspension following a capital raising announcement. The document is short (598 characters) and serves as a notice rather than a detailed report. It does not contain financial statements or detailed financial data. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other specific categories like Capital/Financing Update (CAP) because it does not provide details of the capital raising itself, only references it.
2025-10-27 English
8-K
Regulatory Filings
2025-10-24 English
Trading Halt 2 pages 226.3KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Anteris Technologies Global Corp. regarding a trading halt requested pending the release of an announcement related to a proposed capital raising. The text explicitly states the halt is requested under ASX Listing Rule 17.1 and is pending an announcement about a capital raising. There is no financial data, report, or detailed analysis included, only a notification of the trading halt and the reason for it. The document length is short (2480 characters), and it serves as an announcement rather than a report or detailed filing. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2025-10-23 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.